BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32394837)

  • 1. Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy.
    Esim O; Ozkan CK; Sarper M; Savaser A; Ozkan Y
    Curr Drug Deliv; 2020; 17(7):622-628. PubMed ID: 32394837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine-Phospholipid Complex Loaded Lipid Nanoparticles for Improving Drug Loading, Stability, and Efficacy against Pancreatic Cancer.
    Dora CP; Kushwah V; Yadav V; Kuche K; Jain S
    Mol Pharm; 2024 Jun; 21(6):2699-2712. PubMed ID: 38747900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.
    Alibolandi M; Ramezani M; Abnous K; Hadizadeh F
    J Pharm Sci; 2016 May; 105(5):1741-1750. PubMed ID: 27039356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precise engineering of hybrid molecules-loaded macromolecular nanoparticles shows
    Liu D; Zhang W; Liu X; Qiu R
    Drug Deliv; 2021 Dec; 28(1):776-786. PubMed ID: 33866910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy.
    Devulapally R; Foygel K; Sekar TV; Willmann JK; Paulmurugan R
    ACS Appl Mater Interfaces; 2016 Dec; 8(49):33412-33422. PubMed ID: 27960411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
    Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
    Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer.
    Zhang R; Ru Y; Gao Y; Li J; Mao S
    Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of gemcitabine and simvastatin through PLGA polymeric nanoparticles for the treatment of pancreatic cancer: in-vitro characterization, cellular uptake, and pharmacokinetic studies.
    Jamil A; Aamir Mirza M; Anwer MK; Thakur PS; Alshahrani SM; Alshetaili AS; Telegaonkar S; Panda AK; Iqbal Z
    Drug Dev Ind Pharm; 2019 May; 45(5):745-753. PubMed ID: 30632800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.
    Youngren-Ortiz SR; Hill DB; Hoffmann PR; Morris KR; Barrett EG; Forest MG; Chougule MB
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):299-321. PubMed ID: 28277892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer Coated Iron Nanoparticles: Radiolabeling & In vitro Studies.
    Yilmaz S; Ichedef C; Karatay KB; Teksöz S
    Curr Radiopharm; 2021; 14(1):37-45. PubMed ID: 32351192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): In vitro and in vivo.
    Yalcin TE; Ilbasmis-Tamer S; Takka S
    Int J Pharm; 2020 Apr; 580():119246. PubMed ID: 32205141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing for efficient antitumor activity.
    Martín-Banderas L; Sáez-Fernández E; Holgado MÁ; Durán-Lobato MM; Prados JC; Melguizo C; Arias JL
    Int J Pharm; 2013 Feb; 443(1-2):103-9. PubMed ID: 23299085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation.
    Godara S; Lather V; Kirthanashri SV; Awasthi R; Pandita D
    Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110576. PubMed ID: 32228957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Delivery of Photopolymerizable Nanogels Loaded with Gemcitabine for Pancreatic Cancer Therapy: Formulation Design, and in vitro and in vivo Evaluations.
    Yugatama A; Huang YL; Hsu MJ; Lin JP; Chao FC; Lam JKW; Hsieh CM
    Int J Nanomedicine; 2024; 19():3753-3772. PubMed ID: 38686338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugs.
    Chitkara D; Kumar N
    Pharm Res; 2013 Sep; 30(9):2396-409. PubMed ID: 23756758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation of gemcitabine in RGD-modified nanoliposomes improves breast cancer inhibitory activity.
    Cai W; Geng C; Jiang L; Sun J; Chen B; Zhou Y; Yang B; Lu H
    Pharm Dev Technol; 2020 Jun; 25(5):640-648. PubMed ID: 32028816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.
    Wang F; Wang Y; Ma Q; Cao Y; Yu B
    Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1530-1538. PubMed ID: 27894196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
    Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
    J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.
    Dong S; Guo Y; Duan Y; Li Z; Wang C; Niu L; Wang N; Ma M; Shi Y; Zhang M
    Anticancer Drugs; 2018 Aug; 29(7):637-645. PubMed ID: 29846247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.
    Joshi G; Kumar A; Sawant K
    Eur J Pharm Sci; 2014 Aug; 60():80-9. PubMed ID: 24810394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.